We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Hypothermia Treatment Helps Cardiac Arrest Victims

By HospiMedica International staff writers
Posted on 01 Dec 2015
A new study reveals that therapeutic hypothermia (TH) improves survival and neurological outcomes after cardiac arrest in patients with initially non-shockable rhythms.

Researchers at Thomas Jefferson University (Philadelphia, PA, USA), the University of Colorado School of Medicine (Aurora, USA; medschool.ucdenver.edu), and other institutions conducted a retrospective cohort study involving 519 post cardiac-arrest patients with initial non-shockable rhythms to determine whether TH improved their neurologic outcome and survival. More...
Patient and arrest characteristics were used to estimate the propensity to receive TH, including age, sex, location and duration of arrest, and if the arrest was witnessed. To determine the association between TH and outcomes, 201 propensity score matched pairs were compared.

The results showed that TH patients were significantly younger, had longer durations of arrest, and had a higher incidence of asystole as their primary rhythm. Survival to hospital discharge was higher after TH (29%) than after not receiving TH (15%), and cerebral performance was significantly higher for patients who underwent TH (21%) than for patients who did not undergo TH (10%). In all, TH was associated with a 3.5-fold increased likelihood of favorable neurological outcome and 2.8-fold increased likelihood of survival to hospital discharge. The study was published on November 16, 2015, in Circulation.

“Our findings provide further support for the use of TH in patients with initial nonshockable rhythms, given the lack of randomized controlled trial data, and should encourage its use in this patient population while awaiting data from randomized trials,” concluded lead author Sarah Perman, MD, of Thomas Jefferson University, and colleagues. “Regardless of the location of the cardiac arrest, patients who underwent TH were significantly more likely than those who did not receive TH to survive to hospital discharge neurologically intact.”

Therapeutic cooling is among the most potent interventions for hypoxic-ischemic injury, a broad constellation of conditions ranging from cardiac and respiratory arrest to carbon monoxide (CO) and other poisonous gas exposure, and appears to limit tissue damage by reducing oxygen metabolism and inflammation, while maintaining cell membrane integrity. Other studies have shown that HT after cardiac arrest increases patients’ chances of survival by 31% and quality of survival by 41%.

Related Links:

Thomas Jefferson University
University of Colorado School of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.